Search Within

CTCR Scholars

Formats
  1. Meeting Abstract (873)
  2. Journal Article (564)
  3. Review (72)
  4. Research Letter (38)
  5. Editorial (29)
  6. Correspondence (24)
  7. Miscellaneous (17)
  8. Book Section (11)
  9. Guidelines (7)
  10. Conference Paper (4)
Groups
  1. Department of Medicine (1415)
  2. Hematologic Malignancies, Division of (1082)
  3. MSK Grad Students (1018)
  4. Center for Hematologic Malignancies (985)
  5. Master of Science in Clinical and Translational Cancer Research (983)
  6. Survivorship Research (917)

More Groups

People
  1. Sergio Giralt (553)
  2. Miguel-Angel Perales (411)
  3. Michael Scordo (385)
  4. Gunjan Shah (341)
  5. Sean Devlin (333)
  6. Parastoo Dahi (305)

More People

Years
  1. 2025 (98)
  2. 2024 (251)
  3. 2023 (261)
  4. 2022 (230)
  5. 2021 (166)
  6. 2020 (211)

More Years

Publications
  1. Blood (318)
  2. Biology of Blood and Marrow Transplantation (187)
  3. Journal of Clinical Oncology (144)
  4. Annals of Surgical Oncology (83)
  5. Bone Marrow Transplantation (65)
  6. Transplantation and Cellular Therapy (56)

More Publications

Publishers
  1. Elsevier Inc. (390)
  2. American Society of Hematology (372)
  3. American Society of Clinical Oncology (158)
  4. Nature Publishing Group (134)
  5. Springer (102)
  6. American Association for Cancer Research (65)

More Publishers

Results (1639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alterations in driver genes are associated with response to neoadjuvant FOLFIRINOX in patients with nonmetastatic pancreatic ductal adenocarcinoma
    Meeting Abstract

    Ecker, B. L.; Janssen, Q.; Tao, A.; Tansey, W.; D'Angelica, M.; Drebin, J. A.; Jarnagin, W. R.; Kingham, T. P.; Soares, K.; Wei, A. C.
    Journal of the American College of Surgeons (2021)

    Fulltext@MSK | Save
  • Real-world pan-cancer landscape of frameshift mutations (FSM) and their role in predicting responses to immune checkpoint inhibitors (ICI) in patients (pts) with tumors with low tumor mutational burden (TMB)
    Meeting Abstract

    Florou, V.; Floudas, C. S.; Maoz, A.; Naqash, A. R.; Hildebrand, G.; Sokol, E.; Frampton, G. M.; Puri, S.; Swami, U.; Wilky, B. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase II trial of olaparib in combination with ceralasertib in patients with recurrent osteosarcoma
    Meeting Abstract

    Forrest, S. J.; Kinnaman, M. D.; Livingston, J. A.; Vo, K. T.; Merriam, P.; Clinton, C.; Desmith, K.; Cavanaugh, K.; Felicetti, B.; Smith, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Preliminary clinical and biologic results of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab, in advanced solid tumors (KEYNOTE A36)
    Meeting Abstract

    Park, H.; Bendell, J. C.; Messersmith, W. A.; Rasco, D. W.; De Bono, J. S.; Strickler, J. H.; Zhou, L.; Carter, L. L.; Bruey, J. M.; Li, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Update of a phase II, multicenter study of high-dose chemotherapy with autologous stem cell transplant followed by maintenance romidepsin for T-cell lymphoma
    Meeting Abstract

    Khan, N.; Khimani, F.; Shustov, A. R.; Shadman, M.; Ruan, J.; Moskowitz, A. J.; Straus, D. J.; Kumar, A.; Sauter, C. S.; Zelenetz, A. D.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Noninvasive identification of emergent mutations following cytotoxic therapy for lung cancer
    Meeting Abstract

    Moding, E. J.; Hui, A. B.; Murciano-Goroff, Y. R.; Nabet, B.; Schultz, A.; Qiao, Y.; Li, B. T.; Lin, S. H.; Alizadeh, A. A.; Diehn, M.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer
    Meeting Abstract

    Jee, J.; Lebow, E. S.; Murciano-Goroff, Y. R.; Jayakumaran, G.; Shen, R.; Brannon, A. R.; Benayed, R.; Namakydoust, A.; Offin, M.; Paik, P. K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • BRCA reversion mutations in a pan-cancer cohort to reveal BRCA-dependence in select noncanonical BRCA-mutant histologies
    Meeting Abstract

    Murciano-Goroff, Y. R.; Schram, A. M.; Rosen, E.; Janjigian, Y. Y.; Berger, M. F.; Donoghue, M.; Bandlamudi, C.; Drilon, A. E.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A systematic review and meta-analysis
    Meeting Abstract

    Bewersdorf, J. P.; Sheth, A.; Vetsa, S.; Grimshaw, A.; Giri, S.; Podoltsev, N. A.; Gowda, L.; Tamari, R.; Tallman, M. S.; Rampal, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Using mobile wearables to establish sleep bioprofiles in newly diagnosed multiple myeloma (MM) patients
    Meeting Abstract

    Hevroni, G.; Mastey, D.; Tavitian, E.; Derkach, A.; Salcedo, M.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Hultcrantz, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save